You are here:  Home  >  News  >  Business  >  Current Article

Covid-19 Passport from iProov and Mvine Moves Into Trial Phase

By   /  January 13, 2021  /  No Comments

    Print       Email

LONDON, SINGAPORE & CATONSVILLE, Md.–()–Mvine and iProov announce today their design for a simple, secure and widely recognized Covid-19 immunity and vaccination passport will now move into live testing. The Mvine-iProov passport enables a person’s test result or vaccination status to be registered and proved without disclosing their identity, and without the need for extensive new infrastructure.

With additional backing from Innovate UK, which initially funded the development of a successful working prototype, the Mvine-iProov passport will now be tested by Directors of Public Health within the National Health Service (NHS) in the UK. Mvine and iProov aim to complete two trials by 31 March 2021, giving…

Click here to view the original article.

    Print       Email

You might also like...

Anaheim Ducks and Honda Center Select 8×8 Cloud Communications to Transform Employee and Fan Experience

Read More →